Abstract 7009: Discovery of UBX-306 as a potent, selective, and orally bioavailable HPK1 degrader
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Ae-Ran Choi, Na-rae Jeong, Sun-Mi Yoo, Han Wool Kim, So Hyuk Kim, Hyun-Hwi Kim, Sun-Kyoung Im, Miyoung Jang, Hohyun Lee, Jungmin Ahn, Je Ho Ryu, Song Hee Lee
Institution: NeoImmuneTech, Inc. (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409633831